Skip to main content
. Author manuscript; available in PMC: 2013 Jun 6.
Published in final edited form as: Vaccine. 2012 Mar 23;30(26):3965–3974. doi: 10.1016/j.vaccine.2012.03.026

Table 2.

Viral isolation from nasal swabs taken from vaccinated and unvaccinated ponies after challenge with A/eq/Ohio/03 virus.

Group N Egga
(No. ponies
with positive
results) b
Duration of
shedding d
(egg) a
EID50
(per mL)e
PCRf Duration of
shedding d
(PCR)
Monovalent NS 4 1 2 - 3256 2.5
Monovalent NF 4 1 0.67 - 2491 1.67
Trivalent NF 3 0 0 - 2525 0.5
Control NF 4 4c 5 + (0 – 1×104) 3.07×106 5.25
a

virus growth in embryonated eggs. Nasal swab samples (0.1ml, undiluted) were injected into allantoic cavities of each of three 10-day-old eggs. Following incubation, allantoic fluids were harvested and tested for virus by hemagglutination assay. If any one egg tested positive, the swab sample was called virus-positive and the pony from which it originated was counted as shedding virus on that day.

b

results (positive or negative) are cumulative from days 2–5 post-challenge

c

on day 2 post-challenge, only 2 of the 4 ponies were positive by HA assay. On all other days, all 4 ponies were positive.

d

mean number of days of virus shedding

e

value on day 2 post-challenge

f

mean value on day 3 post-challenge (day of peak shedding in control group)

+ = influenza detected, − = influenza not detected